Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
EQ-5D Health Utility Gains with Once-Weekly Semaglutide 2.4 mg in People with MASH and F2/F3 Fibrosis: An Analysis of ESSENCE.
JHEP reports : innovation in hepatology·2026
Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography.
Hepatology communications·2026
Medicare Advantage and Type 2 Diabetes Outcomes.
JAMA internal medicine·2026